Expression of early growth response-1 in colorectal cancer and its relation to tumor cell proliferation and apoptosis
- 29 November 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 31 (2), 788-794
- https://doi.org/10.3892/or.2013.2884
Abstract
Early growth response-1 (Egr-1) is implicated in the regulation of cell growth, proliferation, differentiation and apoptosis. Egr-1 is considered tobe either a tumor-suppressor or tumor-promoter, depending on the cell type and environment. The aim of the present study was to evaluate the expression of Egr-1 in colorectal cancer and its correlation with tumor cell proliferation, apoptosis and clinicopathological features. The expression of Egr-1 in colorectal cancer tissues was investigated by reverse transcription-polymerase chain reaction (RT-PCR), western blotting and immunohistochemistry. Apoptosis was detected by terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL), and cellular proliferative activity was evaluated by immunohistochemical staining with the Ki-67 antibody. Egr-1 expression was significantly elevated in colorectal cancer tissues, when compared to that in the paired normal mucosa at the mRNA and protein levels. In addition, Egr-1 expression was significantly increased in the metastatic lymph node tissues, when compared to that in the non‑metastatic lymph node tissues at the protein level. The mean Ki-67 labeling index (KI) and apoptotic index (AI) values for 158 tumors were 53.6±15.4 and 9.0±1.0, respectively. Higher KI values were significantly associated with distant metastasis. Lower AI values were significantly associated with lymph node metastasis. However, KI or AI values were not associated with patient survival. The mean KI value of Egr-1-positive tumors was significantly higher than that of Egr-1-negative tumors. However, there was no significant difference between Egr-1 expression and AI value. Positive expression of Egr-1 was significantly associated with age, lymphovascular invasion, lymph node and distant metastasis, tumor stage and poor survival. These results indicate that Egr-1 may be associated with colorectal cancer progression via tumor cell proliferation.Keywords
This publication has 32 references indexed in Scilit:
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and ProliferationCell Metabolism, 2008
- Apoptosis: Programmed cell death at a molecular levelSeminars in Arthritis and Rheumatism, 2003
- Apoptosis: biochemical aspects and clinical implicationsClinica Chimica Acta; International Journal of Clinical Chemistry, 2002
- Antisense Egr‐1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injuryJournal of Cellular Biochemistry, 2002
- Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stressNature Medicine, 2000
- Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: Requirement for mesangial cell proliferationKidney International, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Early Growth Response Protein 1 (Egr-1): Prototype of a Zinc-finger Family of Transcription FactorsProgress in Nucleic Acid Research and Molecular Biology, 1995
- Social controls on cell survival and cell deathNature, 1992
- A Nerve Growth Factor-Induced Gene Encodes a Possible Transcriptional Regulatory FactorScience, 1987